GLAUKOS Corp — Director's Dealing 2024

Mar 18, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GLAUKOS Corp (GKOS)
CIK: 0001192448
Period of Report: 2024-03-14

Reporting Person: Thurman Alex R. (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-03-14	Common Stock	A	4955	—	Acquired	58990	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-03-14	Stock Option (Right to Buy)	$55.18	A	1830	Acquired	2032-03-24	Common Stock (1830)	Direct
2024-03-14	Stock Option (Right to Buy)	$49.51	A	8906	Acquired	2033-04-03	Common Stock (1830)	Direct
2024-03-14	Stock Option (Right to Buy)	$85.78	A	8591	Acquired	2034-03-14	Common Stock (8591)	Direct

Footnotes

F1: Granted by the Issuer in the form of restricted stock units which vest over a four-year period, with 25% to vest on each anniversary of the grant date.

F2: Includes 32,599 restricted stock units that have not yet vested or been delivered to the Reporting Person.

F3: Represents a portion of an option to purchase shares of common stock previously granted by the Issuer on March 24, 2022, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period. The Compensation, Nominating & Governance Committee of the Issuer's Board of Directors (the "Compensation Committee") determined on March 14, 2024 that certain of the operational targets had been achieved. The number of shares of common stock subject to the stock option as reported herein consists of the portion of the award that was earned based upon the achievement of the operational targets.

F4: 50% of the portion of the option reported herein will vest and become exercisable in March 2024, and the remaining 50% will vest and become exercisable in December 2024.

F5: Represents an option to purchase shares of common stock previously granted by the Issuer on April 3, 2023 pursuant to the Reporting Person's election to receive a portion of his annual bonus for 2023 in the form of stock options rather than cash (the "Bonus Election"). The Compensation Committee determined on March 14, 2024 the annual bonus payable to the Reporting Person pursuant to the Issuer's 2023 executive bonus plan and the number of shares of common stock subject to the stock option earned by the Reporting Person in accordance with the Bonus Election, subject to continued employment through the vesting date.

F6: The option to purchase common stock will vest on April 1, 2024.

F7: This option was granted on March 14, 2024 and has a four-year vesting schedule in which 25% vests on the first anniversary of the grant date and the remainder vests in equal monthly installments for 36 months thereafter, such that the stock option vests in full on the four-year anniversary of the grant date.